Evidence map›Paper›PMID 37951985›Full record

ArticleNature communications2023

An on-demand bioresorbable neurostimulator.

Dong-Min Lee, Minki Kang, Inah Hyun, Byung-Joon Park, Hye Jin Kim, Soo Hyun Nam, Hong-Joon Yoon, Hanjun Ryu, Hyun-Moon Park, Byung-Ok Choi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Electrical Stimulation Therapy - Dedicated to the Perfect Plastic Repair.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  20. Advances in Symbiotic Bioabsorbable Devices.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Dong-Min Lee *Department of Materials Science and Engineering, Yonsei University, Seoul, 03722, Republic of Korea.ORCID 0000-0002-5964-2636
Minki Kang *School of Advanced Materials Science and Engineering, Sungkyunkwan University (SKKU), Suwon, 16419, Republic of Korea.ORCID 0000-0002-5440-6589
Inah Hyun *Department of Materials Science and Engineering, Yonsei University, Seoul, 03722, Republic of Korea.ORCID 0009-0000-2037-0197
Byung-Joon ParkDepartment of Materials Science and Engineering, Yonsei University, Seoul, 03722, Republic of Korea.
Hye Jin KimDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea.
Soo Hyun NamCell and Gene Therapy Institute (CGTI), Samsung Medical Center, Seoul, 06351, Republic of Korea.
Hong-Joon YoonDepartment of Electronic Engineering, Gachon University, Seongnam, 13120, Republic of Korea.ORCID 0000-0002-5668-3192
Hanjun RyuDepartment of Advanced Materials Engineering, Chung-Ang University, Anseong, 17546, Republic of Korea.ORCID 0000-0002-3268-9661
Hyun-Moon ParkResearch and Development Center, Energy-Mining Co., LTD., Suwon, 16226, Republic of Korea.
Byung-Ok ChoiDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea. bochoi@skku.edu.
Sang-Woo KimDepartment of Materials Science and Engineering, Yonsei University, Seoul, 03722, Republic of Korea. kimsw1@yonsei.ac.kr.ORCID 0000-0002-0079-5806
Yonsei University · KRSamsung Medical Center · KRChung-Ang University · KRGachon University · KRSamsung (South Korea) · KRSungkyunkwan University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioresorbable bioelectronics, with their natural degradation properties, hold significant potential to eliminate the need for surgical removal. Despite notable achievements, two major challenges hinder their practical application in medical settings. First, they necessitate sustainable energy solutions with biodegradable components via biosafe powering mechanisms. More importantly, reliability in their function is undermined by unpredictable device lifetimes due to the complex polymer degradation kinetics. Here, we propose an on-demand bioresorbable neurostimulator to address these issues, thus allowing for clinical operations to be manipulated using biosafe ultrasound sources. Our ultrasound-mediated transient mechanism enables (1) electrical stimulation through transcutaneous ultrasound-driven triboelectricity and (2) rapid device elimination using high-intensity ultrasound without adverse health effects. Furthermore, we perform neurophysiological analyses to show that our neurostimulator provides therapeutic benefits for both compression peripheral nerve injury and hereditary peripheral neuropathy. We anticipate that the on-demand bioresorbable neurostimulator will prove useful in the development of medical implants to treat peripheral neuropathy.

Indexed as

Absorbable ImplantsPeripheral Nerve InjuriesElectric StimulationHumansPhysicsReproducibility of Results

Identifiers

PMID37951985
PMCPMC10640647
OpenAlexW4388593849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.